Cargando…

First person – Andreia Nunes

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Andreia Nunes is first author on ‘ Identification of candidate miRNA biomarkers for faciosc...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405848/
http://dx.doi.org/10.1242/dmm.049244
_version_ 1783746400716062720
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Andreia Nunes is first author on ‘ Identification of candidate miRNA biomarkers for facioscapulohumeral muscular dystrophy using DUX4-based mouse models’, published in DMM. Andreia is a postdoc in the lab of Peter L. Jones at the University of Nevada, Reno School of Medicine, Reno, NV, USA, investigating therapeutics for and disease mechanisms of facioscapulohumeral muscular dystrophy.
format Online
Article
Text
id pubmed-8405848
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-84058482021-08-31 First person – Andreia Nunes Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Andreia Nunes is first author on ‘ Identification of candidate miRNA biomarkers for facioscapulohumeral muscular dystrophy using DUX4-based mouse models’, published in DMM. Andreia is a postdoc in the lab of Peter L. Jones at the University of Nevada, Reno School of Medicine, Reno, NV, USA, investigating therapeutics for and disease mechanisms of facioscapulohumeral muscular dystrophy. The Company of Biologists Ltd 2021-08-24 /pmc/articles/PMC8405848/ http://dx.doi.org/10.1242/dmm.049244 Text en © 2021. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Andreia Nunes
title First person – Andreia Nunes
title_full First person – Andreia Nunes
title_fullStr First person – Andreia Nunes
title_full_unstemmed First person – Andreia Nunes
title_short First person – Andreia Nunes
title_sort first person – andreia nunes
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405848/
http://dx.doi.org/10.1242/dmm.049244